Oliver Illini

13PUBLICATIONS
29CO-AUTHORS
Predictive and prognostic markersMolecular targetsRespiratory diseasesCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jan 28, 2026
Clinical Impact of EGFR Mutation Subtypes on Treatment Outcomes in Advanced Non-Small Cell Lung Cancer: An Austrian Real-World Study.

Caroline Braschel, Hannah Fabikan, Vania Mikaela Rodriguez

|Apr 28, 2025
Multidisciplinary treatment of advanced or metastatic ALK-positive non-small cell lung cancer: Real-world data on Brigatinib combined with local therapy.

Oliver Illini, Hannah Fabikan, Kristina Breitenecker

|Dec 17, 2024
Prognostic Value of PD-L1, BAP-1 and ILK in Pleural Mesothelioma.

Oliver Illini, Michal Benej, Anna Sophie Lang-Stöberl

|Dec 17, 2024
Sleep-Disordered Breathing in Patients with Chronic Heart Failure and Its Implications on Real-Time Hemodynamic Regulation, Baroreceptor Reflex Sensitivity, and Survival.

Anna S Lang-Stöberl, Hannah Fabikan, Maria Ruis

|Oct 16, 2024
Adenosquamous Carcinoma of the Lung: Survival, Radiologic Findings, PD-L1, and Driver Mutations.

Oliver Illini, Hannah Fabikan, Eva Fischer

|Apr 13, 2024
Mobocertinib in Patients with EGFR Exon 20 Insertion-Positive Non-Small Cell Lung Cancer (MOON): An International Real-World Safety and Efficacy Analysis.

Oliver Illini, Felix Carl Saalfeld, Petros Christopoulos

Pageof 3

Frequent Collaborators

9 joint publications

Maximilian Johannes Hochmair

3 joint publications

Anders Vikström

3 joint publications

Stefan Watzka

2 joint publications

Luka Brcic